PhaseRx (PZRXQ) Stock Chart & Stock Price History $0.0001 0.00 (0.00%) As of 08/8/2025 12:38 PM Eastern Add Compare Share Share Chart Stock AnalysisChartShort InterestBuy This Stock PhaseRx Stock Price Performance The PhaseRx (PZRXQ) stock chart highlights key performance trends across multiple timeframes. As of the latest close, PhaseRx traded at $0.00 with a market cap of and volume of 15,000 shares. Receive PZRXQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PhaseRx and its competitors with MarketBeat's FREE daily newsletter. Email Address PZRXQ Stock Chart for Tuesday, August, 12, 2025 PZRXQ Chart by TradingView PhaseRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$0.00$0.00$0.00$0.0015,000 shs$0.0008/08/2025N/A$0.00$0.00$0.0015,000 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart 4Front Ventures Stock Chart Abattis Bioceuticals Stock Chart Abcam Stock Chart Acusphere Stock Chart Aeolus Pharmaceuticals Stock Chart Aesther Healthcare Acquisition Stock Chart Agentix Stock Chart Ainos Stock Chart Receive PZRXQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PhaseRx and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PZRXQ) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PhaseRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PhaseRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access